These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 24361062

  • 1. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.
    J Neurol Sci; 2014 Feb 15; 337(1-2):86-90. PubMed ID: 24361062
    [Abstract] [Full Text] [Related]

  • 2. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K, Dressler D, Woldag H, Koßmehl P, Koch M, Maisonobe P, Reichel G.
    Nervenarzt; 2019 Apr 15; 90(4):361-370. PubMed ID: 30324541
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May 15; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 15; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R.
    Eur J Phys Rehabil Med; 2013 Aug 15; 49(4):483-9. PubMed ID: 23480980
    [Abstract] [Full Text] [Related]

  • 6. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May 15; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 May 15; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.
    Dressler D, Rychlik R, Kreimendahl F, Schnur N, Lambert-Baumann J.
    BMJ Open; 2015 Dec 30; 5(12):e009358. PubMed ID: 26719317
    [Abstract] [Full Text] [Related]

  • 15. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
    Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA.
    Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.
    Ann Readapt Med Phys; 2004 Oct 31; 47(8):555-62. PubMed ID: 15465160
    [Abstract] [Full Text] [Related]

  • 18. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.
    J Am Med Dir Assoc; 2012 Jun 31; 13(5):477-84. PubMed ID: 22521630
    [Abstract] [Full Text] [Related]

  • 19. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E.
    Cerebrovasc Dis; 2003 Jun 31; 15(4):289-300. PubMed ID: 12686794
    [Abstract] [Full Text] [Related]

  • 20. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin a.
    Tomášová Z, Hluštík P, Král M, Otruba P, Herzig R, Krobot A, Kaňovský P.
    J Neuroimaging; 2013 Jul 31; 23(3):337-44. PubMed ID: 22212022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.